Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COLLEGIUM PHARMACEUTICAL, INC Director's Dealing 2015

May 14, 2015

32163_dirs_2015-05-14_b3d23ba1-4ea5-4044-97a2-8ceb71694f5a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2015-05-12

Reporting Person: Frazier Healthcare VI, L.P. (10% Owner)
Reporting Person: FHM VI, L.P. (10% Owner)
Reporting Person: FHM VI, L.L.C. (10% Owner)
Reporting Person: FRAZIER ALAN D (10% Owner)
Reporting Person: Naini Nader J (10% Owner)
Reporting Person: Topper James N (10% Owner)
Reporting Person: Every Nathan R (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-05-12 Common Stock C 582490 Acquired 582490 Direct
2015-05-12 Common Stock C 222231 Acquired 804721 Direct
2015-05-12 Common Stock C 392113 Acquired 1196834 Direct
2015-05-12 Common Stock C 540498 Acquired 1737332 Direct
2015-05-12 Common Stock P 150000 $12.00 Acquired 1887332 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-05-12 Series A Convertible Stock $ C 4019183 Disposed Common Stock (582490) Direct
2015-05-12 Series B Convertible Stock $ C 1533399 Disposed Common Stock (222231) Direct
2015-05-12 Series C Convertible Stock $ C 2705585 Disposed Common Stock (392113) Direct
2015-05-12 Series D Convertible Stock $ C 3676078 Disposed Common Stock (540498) Direct

Footnotes

F1: All series of Convertible Preferred Stock automatically converted into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis immediately prior to the closing of the initial public offering and had no expiration date.

F2: Reflects the conversion of preferred stock into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis which became effective on May 12, 2015.

F3: This report is filed jointly by Frazier Healthcare VI, L.P. ("FHVI"), FHM VI, L.P. ("FHM LP"), FHM VI, LLC ("FHM LLC"), Nathan Every ("Every"), Alan Frazier ("Frazier"), Patrick Heron ("Heron"), Nader Naini ("Naini") and James Topper ("Topper"). The shares are held by FHVI. The general partner of FHVI is FHM LP, a limited partnership, the general partner of which is FHM LLC. The members of FHM LLC are Every, Frazier, Naini, Heron, and Topper. These individuals share voting and investment power over the shares held by FHVI. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.